EU DECLARATION OF CONFORMITY Document number: ALABA333101220208 Following the provisions of the medical device’s regulation 2017/745 (EU MDR). We: Legal Manufacturer CV. Anggrek-Liar Jalan Jomblang Barat 666 RT 09 RW 03 Kelurahan Candi, Kecamatan Candisari Semarang 50257 Central Java REPUBLIC OF INDONESIA EU Authorized Representative Kaio-Dia Europe Sasu 12, rue Bertrand 31480 Lagraulet Saint Nicolas, France Single Registration Number (SRN) ID-MF-000037819 Single Registration Number (SRN) FR-AR-000037267 Manufacturing Sites Anggrek-Liar / Kaio-Care Jalan Tumpang IV No. 38 Kelurahan Bendan Ngisor Kecamatan Gajahmungkur Semarang 50233 Central Java REPUBLIC OF INDONESIA Declare under our sole responsibility for the universal device fixation support: Kaio-Dia® Dia-Band Night & Day© Non-Invasive Arm Sleeves Basic UDI-DI: 8994228UA-ABA12-NDW4 Identification number: See Appendix 1 Date: 01 July 2024 SIGNATURE: Date of Issue Place of Issue Name Function Semarang, Central Java, Indonesia Anik Susilawatiningsih Regulatory Affairs Manager This Declaration of Conformity relating to Technical Documentation DOC333ABA56272 supersedes the previous Declaration signed 01-December-2021.

Intended Purpose: Kaio-Dia® Dia-Band Night & Day©, arm sleeves are independently developed as universal after market accessories used to provide additional fixation support for a wide variety of medical devices, such as CGM and insulin patch pump, that in their native forms are attached to the skin with an adhesive fixation. (see attachment Appendix 1 – List of Supported Product version #3) Dia-Bands Night & Day© are available in adult sizes and several color are non-sterile and may be reused (intended for single patient use only). The devices are not designed or sold for use other than indicated....

Appendix 1 - List of Supported Product Date 01-07-2024 version #003 Date of Issue Place of Issue Name Function Semarang, Central Java, Indonesia Anik Susilawatiningsih Regulatory Affairs Manager This Declaration of Conformity relating to Technical Documentation DOC333ABA56272 supersedes the previous Declaration signed 01-December-2021.